首页 › 基金 › Crestline Management, L.P. › DNLI

Crestline Management, L.P. 对 DNLI 的持仓历史

DENALI THERAPEUTICS INC · 医疗保健

Crestline Management, L.P. 在 Q2 2026 的 13F 申报中披露持有 DNLI(DENALI THERAPEUTICS INC)1,910,732 股,市值约 US$49.1M,约占其申报组合的 91.90%,在其申报持仓中市值排名第 1 位。 Crestline Management, L.P. 最近 12 个申报季度中有 12 个季度披露了 DNLI 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q2 2026)1.91M 股
申报持仓市值$49.14M
组合权重91.90%
首次申报Q3 2023
最近变动减持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Crestline Management, L.P. 对 DNLI 的持仓演变

Crestline Management, L.P. 于 Q3 2023 首次披露 DNLI 持仓:5,960,732 股(约 US$123.0M)。 该持仓在 Q3 2024 达到峰值 4,460,732 股,市值约 US$129.9M。 在 12 次申报中,Crestline Management, L.P. 0 次增持、11 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 1,910,732 股、市值约 US$49.1M,环比减持 -300,000 股。。

逐季持仓明细

季度股数金额变化
Q3 2023 5.96M $122.97M 新进
Q4 2023 5.66M $121.48M 减持
Q1 2024 5.21M $106.92M 减持
Q2 2024 4.76M $110.54M 减持
Q3 2024 4.46M $129.94M 减持
Q4 2024 4.31M $87.85M 减持
Q1 2025 4.16M $56.57M 减持
Q2 2025 3.86M $54.01M 减持
Q3 2025 3.41M $49.52M 减持
Q4 2025 2.81M $46.41M 减持
Q1 2026 2.21M $42.45M 减持
Q2 2026 1.91M $49.14M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 DNLI 与 13F 数据

DNLI(DENALI THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 DNLI,申报仓位最大的包括:淡马锡控股 (US$180.4M), Temasek Holdings (Private) Ltd (US$180.4M), BAKER BROS. ADVISORS LP (US$96.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 DNLI 的基金

查看 DNLI 的全部基金持有人 →

常见问题

How long has Crestline Management, L.P. held DNLI?

Crestline Management, L.P. has disclosed DNLI holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Crestline Management, L.P.'s current position in DNLI?

As of Q2 2026, Crestline Management, L.P. holds 1.91M shares of DNLI (DENALI THERAPEUTICS INC), valued at $49.14M, representing 91.90% of its reported portfolio and ranking #1.

Has Crestline Management, L.P. been buying or selling DNLI?

In the latest 13F filing (Q2 2026), Crestline Management, L.P. reduced its position in DNLI. The position peaked in Q3 2024 at 4.46M shares.

Which other funds hold DNLI?

Other major institutional holders of DNLI include 淡马锡控股, Temasek Holdings (Private) Ltd, BAKER BROS. ADVISORS LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.